MoonLake Immunotherapeuti Stock Forward View - Triple Exponential Smoothing
| MLTX Stock | USD 18.34 0.19 1.05% |
Momentum 58
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter -0.90 | EPS Estimate Current Year -3.76 | EPS Estimate Next Year -3.74 | Wall Street Target Price 23.8571 | EPS Estimate Current Quarter -0.94 |
This section frames MoonLake Immunotherapeutics response to recent headlines in a peer context. Sentiment context here is built from MoonLake Immunotherapeuti's options activity and short interest data.
Short Interest Map for MoonLake Immunotherapeuti
MoonLake Immunotherapeuti's short interest, when combined with volume and price trend analysis, helps investors assess whether selling pressure in MoonLake is likely to persist or abate.
200 Day MA 30.1654 | Short Percent 0.2039 | Short Ratio 5.25 | Shares Short Prior Month 7 M | 50 Day MA 15.9673 |
MoonLake RSI Indicator
The Triple Exponential Smoothing forecasted value of MoonLake Immunotherapeutics on the next trading day is expected to be 18.40 with a mean absolute deviation of 0.51 and the sum of the absolute errors of 30.75.Hype-Price Trend View - MoonLake Immunotherapeuti
MoonLake Immunotherapeuti's market sentiment is a measurable proxy for investor optimism or fear. Monitoring changes in sentiment trend alongside price data gives early warning of potential reversals in MoonLake.
For MoonLake Immunotherapeuti, sentiment-adjusted positioning means sizing exposure relative to how extreme the current market mood has become. High positive sentiment with elevated valuation is a classic signal to reduce risk.
MoonLake Immunotherapeuti Implied Volatility | 1.3 |
For long-term investors in MoonLake Immunotherapeuti, monitoring MoonLake Immunotherapeuti's implied volatility helps assess whether hedging costs are reasonable and whether the options market is pricing in unusually high uncertainty.
The Triple Exponential Smoothing forecasted value of MoonLake Immunotherapeutics on the next trading day is expected to be 18.40 with a mean absolute deviation of 0.51 and the sum of the absolute errors of 30.75.MoonLake Immunotherapeuti after-hype prediction price | USD 18.22 |
This view helps relate attention signals to forecasting and technical indicators plus earnings context.
Historical Fundamental Analysis of MoonLake Immunotherapeuti provides a cross-check on projections for MoonLake Immunotherapeuti. The analysis adds historical context for the projection set.Rule 16 Summary for current MoonLake contract - Market Context
Rule 16 converts implied volatility into an estimated daily move of about 0.0813% for 2026-05-15 options. At a recent price around USD 18.34, the implied daily move is approximately USD 0.0149 , which is informational only.
Open Interest Coverage for 2026-05-15 MoonLake Option Contracts
Outstanding MoonLake Immunotherapeuti options are captured via open interest, which provides contract-flow context.
MoonLake Immunotherapeuti Additional Predictive Modules
Most predictive techniques to examine MoonLake price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MoonLake using various technical indicators. When you analyze MoonLake charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
MoonLake Immunotherapeuti Triple Exponential Smoothing Price Forecast For the 11th of March 2026
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of MoonLake Immunotherapeutics on the next trading day is expected to be 18.40 with a mean absolute deviation of 0.51 , mean absolute percentage error of 0.73 , and the sum of the absolute errors of 30.75 .Please note that although there have been many attempts to predict MoonLake Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that MoonLake Immunotherapeuti's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
MoonLake Immunotherapeuti Stock Forecast Pattern
| Backtest MoonLake Immunotherapeuti | MoonLake Immunotherapeuti Price Prediction | Research Analysis |
MoonLake Immunotherapeuti Forecasted Value
This next-day forecast for MoonLake Immunotherapeutics uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of MoonLake Immunotherapeuti stock data series using in forecasting. Note that when a statistical model is used to represent MoonLake Immunotherapeuti stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0022 |
| MAD | Mean absolute deviation | 0.5125 |
| MAPE | Mean absolute percentage error | 0.0328 |
| SAE | Sum of the absolute errors | 30.75 |
The degree to which MoonLake Immunotherapeuti's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
MoonLake Immunotherapeuti After-Hype Price Density Analysis
The after-hype price distribution for MoonLake Immunotherapeuti helps investors understand how much of MoonLake Immunotherapeuti's predicted return comes from the central scenario versus tail outcomes. Strategies that rely on tail events for MoonLake Immunotherapeuti are inherently more speculative.
Next price density |
| Expected price to next headline |
MoonLake Immunotherapeuti Estimiated After-Hype Price Volatility
Historical news patterns for MoonLake Immunotherapeuti reveal how the market has historically digested different types of information about MoonLake Immunotherapeuti's business and market environment. MoonLake Immunotherapeuti's after-hype downside and upside margins for the prediction period are 12.03 and 24.41, respectively. The model extrapolates these patterns to estimate likely price boundaries following the next significant.
Current Value
The after-hype framework applied to MoonLake Immunotherapeutics assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
MoonLake Immunotherapeuti Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as MoonLake Immunotherapeuti is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MoonLake Immunotherapeuti backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MoonLake Immunotherapeuti, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.55 | 6.24 | 0.12 | 0.04 | 11 Events | 7 Events | In 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
18.34 | 18.22 | 0.65 |
|
MoonLake Immunotherapeuti Hype Timeline
MoonLake Immunotherapeuti is now traded for 18.34. The entity has historical hype elasticity of -0.12, and average elasticity to hype of competition of -0.04. MoonLake is anticipated to decline in value after the next headline, with the price expected to drop to 18.22. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.65%, whereas the daily expected return is now at 0.55%. The volatility of related hype on MoonLake Immunotherapeuti is about 8914.29%, with the expected price after the next announcement by competition of 18.30. About 81.0% of the company shares are owned by institutional investors. The book value of MoonLake Immunotherapeuti was now reported as 4.27. The company recorded a loss per share of 3.53. MoonLake Immunotherapeuti had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in 11 days. Historical Fundamental Analysis of MoonLake Immunotherapeuti provides a cross-check on projections for MoonLake Immunotherapeuti. The analysis adds historical context for the projection set.MoonLake Immunotherapeuti Related Hype Analysis
Peer hype analysis helps investors build a more complete picture of MoonLake Immunotherapeuti's competitive environment by quantifying the market's sensitivity to news across all major players in MoonLake Immunotherapeuti's sector.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RGNX | Regenxbio | 0.20 | 11 per month | 0.00 | -0.09 | 6.52 | -7.96 | 25.89 | |
| MBX | MBX Biosciences Common | 0.02 | 9 per month | 4.82 | 0.01 | 13.41 | -7.57 | 29.11 | |
| ABSI | Absci Corp | 0.12 | 10 per month | 0.00 | -0.05 | 8.58 | -8.21 | 27.80 | |
| VSTM | Verastem | -0.49 | 11 per month | 0.00 | -0.16 | 5.85 | -7.51 | 19.78 | |
| MGTX | MeiraGTx Holdings PLC | 0.14 | 8 per month | 0.00 | -0.05 | 4.77 | -5.67 | 16.37 | |
| ERAS | Erasca Inc | 0.35 | 7 per month | 2.27 | 0.37 | 15.04 | -4.17 | 50.26 | |
| VTYX | Ventyx Biosciences | -0.01 | 7 per month | 2.74 | 0.12 | 9.00 | -6.33 | 37.04 | |
| AVBP | ArriVent BioPharma Common | 0.38 | 5 per month | 3.21 | 0.03 | 7.49 | -6.11 | 18.12 | |
| OLMA | Olema Pharmaceuticals | -1.40 | 7 per month | 0.00 | -0.07 | 8.11 | -6.33 | 24.77 | |
| CTMX | CytomX Therapeutics | -0.01 | 9 per month | 3.87 | 0.05 | 8.13 | -6.59 | 36.75 |
Other Forecasting Options for MoonLake Immunotherapeuti
The price trajectory of MoonLake is the primary concern for any investor assessing it as an opportunity. MoonLake Stock price charts are filled with noise that can easily mislead uninformed investment decisions.MoonLake Immunotherapeuti Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MoonLake Immunotherapeuti stock to make a market-neutral strategy. Peer analysis of MoonLake Immunotherapeuti could also be used in its relative valuation, which is a method of valuing MoonLake Immunotherapeuti by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
MoonLake Immunotherapeuti Market Strength Events
Understanding the market strength of MoonLake Immunotherapeuti stock enables investors to assess the security's momentum and responsiveness to broader market forces. These indicators are essential tools for timing trades in MoonLake Immunotherapeutics with greater precision.
MoonLake Immunotherapeuti Risk Indicators
Reviewing MoonLake Immunotherapeuti's basic risk indicators is essential for investors who want to forecast its price and manage their investment risk effectively. This analysis helps identify the amount of risk involved in holding MoonLake Immunotherapeuti's and informs decisions about hedging and position.
| Mean Deviation | 3.62 | |||
| Semi Deviation | 3.52 | |||
| Standard Deviation | 6.23 | |||
| Variance | 38.87 | |||
| Downside Variance | 15.57 | |||
| Semi Variance | 12.38 | |||
| Expected Short fall | -4.33 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for MoonLake Immunotherapeuti
Coverage intensity for MoonLake Immunotherapeutics matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
MoonLake Immunotherapeuti Short Properties
Short sentiment tied to MoonLake Immunotherapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 64.5 M | |
| Cash And Short Term Investments | 394 M |
More Resources for MoonLake Stock Analysis
A structured review of MoonLake Immunotherapeuti often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Moonlake Immunotherapeutics Stock. Highlighted below are reports that provide context for Moonlake Immunotherapeutics Stock:Historical Fundamental Analysis of MoonLake Immunotherapeuti provides a cross-check on projections for MoonLake Immunotherapeuti. The analysis adds historical context for the projection set. Analysis related to MoonLake Immunotherapeuti should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Investors evaluate MoonLake Immunotherapeuti using market value and book value, each describing different facets of the business. Intrinsic value is an estimate of what MoonLake Immunotherapeuti's fundamentals imply, and it may differ from market and book figures. External forces such as sentiment and macro conditions can shift prices away from fundamental signals. Analytical frameworks help compare those viewpoints.
Value and price for MoonLake Immunotherapeuti are related but not identical, and they can diverge across cycles. Evaluation typically reviews profitability, growth, balance sheet strength, industry position, and market signals. By contrast, market price reflects the level where buyers and sellers transact.